- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
EXHIBIT 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements (Form S-8 Nos. 333-131619 and 333-135356 and Form S-3 Nos. 333-133501, 333-139054 and 333-139260) of CombinatoRx, Incorporated and in the related Prospectuses of our reports dated March 12, 2007, with respect to the consolidated financial statements of CombinatoRx, Incorporated, CombinatoRx, Incorporated’s management’s assessment of the effectiveness of internal control over financial reporting, and the effectiveness of internal control over financial reporting of CombinatoRx, Incorporated included in this Annual Report (Form 10-K) for the year ended December 31, 2006.
/s/ Ernst & Young LLP |
| ||
|
|
| |
Boston, Massachusetts |
|
| |
March 12, 2007 |
|
| |